| |
| Board Of Directors |
| The Board of Governance holds the fiduciary responsibility for the company ensuring the Shareholders interest are protected. The Board sets the standards for the company, officers and management. |
| Kenneth L. Harris – Chairman and Chief Executive Officer |
| Kenneth L. Harris has more than 25 years of experience in the healthcare and biotechnology industries. He currently serves as the Chairman of MK Alliance, Inc., a position Ken has held for the past three years. Prior to co-founding MK Alliance, he was the President of Pall Corporation’s BioScience and Cellular Therapy Business Units from 2001 to 2008. |
| Mitchel Sivilotti – Non-Executive Director |
| Mitchel M. Sivilotti, a recognized consultant and expert in the field of cord blood banking, and presently serving as the President of TotipotentSC, and Vice Chairman of MK Alliance, Inc. Prior to co-founding MK Alliance, Mitchel was the Commercial Leader for cord blood systems and devices at Pall Corporation. |
| Gary Cohan, M.D., F.A.C.P. – Non-Executive Director |
| Dr. Gary Cohan is a globally recognized clinical research physician in the field of infectious disease. Dr. Cohan has been a practicing physician for twenty four years. |
| Gernot Rehra – Non-Executive Director |
| Gernot Rehra – currently serves as the Director, TFCMC Global Business Management for Deutsche Bank in Frankfurt, Germany. Gernot has been in the financial banking sector for nineteen years. |